NEW GENETIC METHODS TO IMPROVE SECONDARY METABOLITE PRODUCTION IN STREPTOMYCES

Authors
Citation
Rh. Baltz, NEW GENETIC METHODS TO IMPROVE SECONDARY METABOLITE PRODUCTION IN STREPTOMYCES, Journal of industrial microbiology & biotechnology, 20(6), 1998, pp. 360-363
Citations number
30
Categorie Soggetti
Biothechnology & Applied Migrobiology
Volume
20
Issue
6
Year of publication
1998
Pages
360 - 363
Database
ISI
SICI code
Abstract
The most potent chemical mutagens commonly used for yield enhancement in streptomycetes induce a limited spectrum of base-pair substitutions , heavily dominated by GC to AT transitions. The AT to CG transversion pathway complements the GC to AT pathway, but no strong mutagens with this specificity are available. However, mutT mutations in Escherichi a coli enhance spontaneous AT to CG transversions about 1000-fold, so such mutations in streptomycetes could be very beneficial for random m utagenesis. Rate-limiting steps in secondary metabolite biosynthesis, on the other hand, can be best addressed by cloning and insertion of e xtra copies of the appropriate gene(s) into a neutral genomic site. Th is approach has been used successfully to improve the production of ty losin and pristinomycin. Transposon mutagenesis can be used to identif y and clone neutral genomic sites, as demonstrated in Streptomyces fra diae to improve tylosin yields. Transposon mutagenesis can also be use d to activate or enhance the transcription of genes important for seco ndary metabolite production, and to identify and clone both positive a nd negative regulatory elements. In some cases it may be advantageous to amplify the complete biosynthetic pathway for secondary metabolite production. In Streptomyces rimosus, a highly productive oxytetracycli ne producer was shown to contain the complete biosynthetic pathway nea r the end of the linear chromosome, and on a hybrid linear plasmid tha t had undergone recombination with the chromosome, This concept of lin ear replicon fusion might be applicable to other secondary metabolite pathway genes that are located near one end of the linear chromosome.